Clinical trial
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
NCT07069738 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- October 22, 2025
- Completion date
- November 30, 2029
- Enrollment
- 850 (estimated)
- Sites
- 42
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure - nyha ii - iv